OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? [Yahoo! Finance]
OptimizeRx Corporation (OPRX)
NASDAQ:AMEX Investor Relations:
optimizerx.com/investors
Company Research
Source: Yahoo! Finance
Both the top and bottom lines comfortably beat their consensus mark. Strong adjusted EBITDA of $5.8 million and expanding gross margins underscored operational leverage, while management raised full-year revenue guidance to $104-$108 million. Importantly, contracted revenues climbed over 30%, signaling growing customer confidence in OPRX's integrated solutions. At the core of its strategy is AI-driven workflow integration. The company's omnichannel platform, bolstered by tools like DAAP and micro-neighborhood targeting, is reshaping digital pharma marketing by connecting physicians, patients, and life sciences firms in real time. This integration is critical as pharma increasingly prioritizes efficient script lift and reduced abandonment in an environment marked by regulatory uncertainty and a shift toward specialty medications. Management highlighted the scalability of its tech stack, noting operating expenses remained flat despite double-digit top-line growth — a sign of meaning
Show less
Read more
Impact Snapshot
Event Time:
OPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPRX alerts
High impacting OptimizeRx Corporation news events
Weekly update
A roundup of the hottest topics
OPRX
News
- How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]Yahoo! Finance
- OptimizeRx (NASDAQ:OPRX) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- OptimizeRx (NASDAQ:OPRX) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.MarketBeat
- OptimizeRx (NASDAQ:OPRX) had its price target lowered by analysts at Stephens from $20.00 to $17.00. They now have an "equal weight" rating on the stock.MarketBeat
- OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
OPRX
Earnings
- 11/6/25 - Beat
OPRX
Sec Filings
- 11/10/25 - Form 4
- 11/10/25 - Form 3
- 11/7/25 - Form 4
- OPRX's page on the SEC website